A n obese 35-year-old woman presented with an asymptomatic "rash" on the side of her neck of 3 years' duration (Figure 1) . Despite vigorous cleansing and use of bleaching creams, the discoloration remained unchanged. In addition, the patient had noted "sores" on her leg over the preceding year that were unresponsive to topical antibiotics (Figure 2) . On examination, well-circumscribed yellowish atrophic patches were noted on her shins, and a velvety, brownish discoloration was present on the sides of her neck.
BAYLOR UNIVERSITY MEDICAL CENTER PROCEEDINGS VOLUME 15, NUMBER 3 DIAGNOSIS: Acanthosis nigricans ( Figure 1 ) and necrobiosis lipoidica diabeticorum (NLD) (Figure 2 ), which are cutaneous manifestations of diabetes mellitus.
DISCUSSION
Cutaneous findings associated with diabetes are summarized in Table 1 . They include acanthosis nigricans and NLD, both seen in this patient, as well as bullous diabeticorum, diabetic dermopathy, eruptive xanthomas, generalized granuloma annulare, infections (yeast or bacterial), neuropathic foot ulcers, and scleredema. In addition, waxy, yellowish skin may be seen on fingers and hands.
Acanthosis nigricans most often appears as velvety, hyperpigmented patches on the neck, axillae, and inner thighs (1). Insulin resistance or overt diabetes mellitus is commonly present in patients with acanthosis nigricans (2) . Other less common associations include medications (i.e., nicotinic acid), pituitary tumors, thyroid disorders, and ataxia telangiectasia syndrome (1) . If acanthosis nigricans occurs over the palms (also called tripe palm) or involves the lips or mucosa, an internal malignancy, usually involving stomach or lung, may be present (3). "Pseudo" acanthosis nigricans may be seen in obese patients with no evidence of underlying diabetes.
Treatment of acanthosis nigricans should concentrate first on finding the underlying cause. After all reversible causes have been addressed, therapy can be instituted. Topical and systemic retinoids (1), topical calcipotriol (4), and fish oil (5) have been advocated, but improvement is slow and often incomplete.
NLD occurs predominantly in middle-aged women as wellcircumscribed yellow-brown atrophic patches. Lesions of NLD may occur anywhere; however, there is a predilection for the shins. These lesions are chronic, are asymptomatic, and, while of cosmetic concern, may also be painful-especially if ulcerated. The lesions may be single or multiple, with slow, gradual enlargement of individual lesions occurring over the years. Spontaneous involution may occasionally be noted. Ulceration may rarely herald the development of a skin cancer in the area of NLD (6) .
While <1% of diabetic patients have NLD, the majority of patients with NLD have diabetes mellitus (usually insulin dependent), an abnormal glucose tolerance test result, or a strong family history of diabetes (7, 8) . In diabetic patients with NLD, there is no apparent relation between the occurrence of lesions and the degree of glucose control or the duration of diabetes (8, 9) . NLD usually develops years after the onset of diabetes. The etiology of NLD is unknown; however, immune complex deposition with vascular changes is considered the most important factor.
Numerous treatment options exist for NLD (Table 2 ). In our experience, the use of class I potent topical steroids carefully applied to individual patches under occlusion leads to significant improvement, usually within weeks. Platelet aggregation inhibitors (aspirin, dipyridamole) 12
Fibrinolytic agents (pentoxifylline) 13
Chloroquine 14
Psoralen + ultraviolet A phototherapy 15
Granulocyte-macrophage colony-stimulating factor 16
Hyperbaric oxygen
